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OBJECTIVEdOptimizing glycemic control in type 1 diabetes is important to minimize the
risk of complications. We used the large T1D Exchange clinic registry database to identify
characteristics and diabetes management techniques in adults with type 1 diabetes, differentiat-
ing those under excellent glycemic control from those with poorer control.
RESEARCHDESIGNANDMETHODSdThe cross-sectional analysis included 627 par-
ticipants withHbA1c,6.5% (excellent control) and 1,267with HbA1c$8.5% (fair/poor control)
at enrollment who were $26 years of age (mean 6 SD 45.9 6 13.2 years), were not using
continuous glucose monitoring, and had type 1 diabetes for $2 years (22.8 6 13.0 years).
RESULTSdCompared with the fair/poor control group, participants in the excellent control
group had higher socioeconomic status, were more likely to be older andmarried, were less likely
to be overweight, were more likely to exercise frequently, and had lower total daily insulin dose
per kilogram (P , 0.0001 for each). Excellent control was associated with more frequent self-
monitoring of blood glucose (SMBG), giving mealtime boluses before a meal rather than at the
time of or after a meal, performing SMBG before giving a bolus, and missing an insulin dose less
frequently (P, 0.0001 for each). Frequency of severe hypoglycemiawas similar between groups,
whereas diabetic ketoacidosis was more common in the fair/poor control group.
CONCLUSIONSdDiabetes self-management related to insulin delivery, glucosemonitoring,
and lifestyle tends to differ among adults with type 1 diabetes under excellent control compared
with those under poorer control. Future studies should focus on modifying diabetes manage-
ment skills in adult type 1 diabetes patients with suboptimal glycemic control.
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The Diabetes Control and Complica-tions Trial (DCCT) demonstratedthat lowering average blood glucose
levels leads to decreased microvascular
and macrovascular complications (1,2).
In the intervening years, much advance-
ment has been made in an attempt to im-
prove diabetes management through the
development of insulin analogs, im-
provement of insulin infusion pumps,
and development of continuous glu-
cose monitoring (CGM) systems. Certi-
fied diabetes education programs provide
evidence-based information to patients on
ways to achieve optimal diabetes control,
and in the current digital era, information
about the carbohydrate content of food is
at the fingertips of many patients. How-
ever, although some patients have excel-
lent glycemic control on the basis of
HbA1c values, it is not always apparent
how their diabetes management differs
from patients who have poor diabetes
control. The large T1D Exchange clinic
registry database provides an opportu-
nity to cross-sectionally analyze differen-
ces in patient characteristics as well as
aspects of diabetes management in adult
patients with HbA1c values in the excel-
lent range compared with those with val-
ues in the fair/poor range.
RESEARCH DESIGN AND
METHODSdThe T1D Exchange Clinic
Network includes 67 U.S. pediatric and
adult endocrinology practices. A registry of
individuals with type 1 diabetes com-
menced enrollment in September 2010
(3). Each clinic received approval from an
institutional review board, and informed
consent was obtained from adult partici-
pants and parents or guardians of minors;
assent from minors was obtained as re-
quired. Data were collected for the regis-
try’s central database from participant
medical records and by having the partici-
pant or parent complete a comprehensive
questionnaire, as previously described (3).
To have a substantial separation be-
tween groups with regard to HbA1c val-
ues, excellent glycemic control was
arbitrarily defined as an average HbA1c
,6.5% in the past 12 months and fair/
poor control as an average HbA1c
$8.5% in the past 12 months. The pres-
ent report includes data on participants en-
rolled through 1 August 2012 who were
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$26 years of age, had type 1 diabetes for
$2 years, and had an average HbA1c level
in the 12 months before enrollment of ei-
ther,6.5 or$8.5%. The lower limit of 26
years was used because the registry data in-
dicate that participants 18–25 years of age
more closely resembled 13–17 year olds
than older adults. Participants for whom
data were not available to characterize as
either a pump or injection user were ex-
cluded. In addition, users of real-time
CGM were excluded because key aspects
of diabetes management might differ
between CGM users and nonusers, and
the percentage of CGM users was small.
Of the 5,475 T1D Exchange clinic reg-
istry participants meeting the non-
HbA1c inclusion criteria, 11% (n =
627) were classified as having excellent
control (HbA1c ,6.5%), and 23% (n =
1,267) were classified as having fair/
poor control (HbA1c $8.5%); the other
65% (n = 3,581) with HbA1c between
6.5 and 8.4% were not included in the
analyses.
Data used in the analyses were ob-
tained from a questionnaire completed by
the participant, the elements of which
included questions about diabetes man-
agement, lifestyle (marital and employ-
ment status, exercise), family history, and
socioeconomic factors. BMI was deter-
mined from height and weight measure-
ments at the most recent office visit.
HbA1c levels, mainly measured with
point-of-care devices (60% DCA 2000
[Bayer] and DCA Vantage [Siemens], 6%
other point-of-care devices, 38% labo-
ratory, 2% unknown), were obtained
from the clinic chart. The mean 6 SD
number of HbA1c values per participant
was 2.9 6 1.3 in the excellent control
group and 2.6 6 1.3 in the fair/poor
control group. Severe hypoglycemia
(SH) was defined as the occurrence of
hypoglycemia-induced seizure or loss
of consciousness. Diabetic ketoacidosis
(DKA) was defined as the occurrence of
ketoacidosis that resulted in overnight
hospitalization.
Characteristics between the excellent
control versus fair/poor control groups
were compared by t test for continuous
variables and x2 test for categorical vari-
ables (Mantel-Haenszel statistics for or-
dered categories). Separate analyses were
conducted for insulin pump and injection
users. Analyses initially were conducted
in four age-groups (26–,31, 31–,50,
50–,65, and$65 years) but then pooled
across age-groups because results among
the age-groups appeared similar. In view
of the large sample size and number of
variables evaluated, only P , 0.01 was
considered to be meaningful. SAS version
9.3 (SAS Institute, Cary, NC) was used for
the analyses.
RESULTSdThe characteristics of the
627 participants with excellent control
and 1,267 with fair/poor control are
shown in Table 1. Compared with the
fair/poor control group, the excellent






(n = 1,267) P value
Age (years) 47.6 6 14.2 45.0 6 12.6 0.0001
Age-group
26–,31 years 81 (13) 198 (16)
31–,50 years 286 (46) 632 (50)
50–,65 years 172 (27) 354 (28)
$65 years 88 (14) 83 (7)
Female sex 316 (50) 712 (56) 0.02
Race/ethnicity ,0.0001
White non-Hispanic 582 (93) 1,071 (85)
Black non-Hispanic 7 (1) 101 (8)
Hispanic or Latino 19 (3) 49 (4)
Other race/ethnicity 17 (3) 41 (3)
Duration of type 1 diabetes (years) 22.9 6 14.7 22.7 6 12.1 0.7
BMIa (kg/m2) 26.0 6 4.8 28.2 6 5.9 ,0.0001
BMI category
Normal/underweight
(14.5–,25 kg/m2) 231 (48) 293 (32)
Overweight (25–,30 kg/m2) 172 (36) 336 (37)
Obese ($30 kg/m2) 78 (16) 285 (31)
Household incomeb ,0.0001*
,$25,000 33 (7) 184 (20)
$25,000–,$50,000 77 (16) 243 (26)
$50,000–,$75,000 87 (18) 196 (21)
$$75,000 281 (59) 311 (33)
Educationc ,0.0001*
Less than a high school diploma 10 (2) 61 (5)
High school diploma/GED 130 (22) 514 (45)
Associate’s degree 41 (7) 146 (13)
Bachelor’s degree 218 (37) 291 (25)
Master’s degree, doctorate,
or professional degree 184 (32) 135 (12)
Insurance statusd ,0.0001
Private 428 (85) 735 (69)
Other 70 (14) 274 (26)
No insurance 8 (2) 54 (5)
Marital status ,0.0001
Living alonee 133 (22) 471 (40)
Married/living together 464 (78) 718 (60)
Employment status 0.3
Student 14 (2) 32 (3)
Working full/part time 372 (63) 703 (60)
Not working 208 (35) 445 (38)
Data are mean6 SD or n (%). GED, general educational development. *Mantel-Haenszel x2 statistics. aOne
hundred forty-six participants missing BMI in the excellent control group and 353 in the fair/poor control
group because of unavailable height or weight data. bOne hundred forty-nine participants missing household
income data in the excellent control group and 333 in the fair/poor control group. cForty-four participants
missing education data in the excellent control group and 120 in the fair/poor control group. dAnalysis is
limited to those,65 years of age because of availability of Medicare insurance to all$65 years of age. Thirty-
three participants missing insurance data in the excellent control group and 121 in the fair/poor control
group. eIncludes single, separated, divorced, and widowed.
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control group on average was 2.6 years
older; less likely to have a BMI in the over-
weight or obese range; more likely to be
white non-Hispanic; more likely to have a
higher income, higher education level,
and private insurance; and more likely
to be married (P, 0.0001 for each). Du-
ration of diabetes was similar in the two
groups. In the excellent control group,
336 (54%) were using an insulin pump
comparedwith 580 (46%) in the fair/poor
control group (P = 0.001).
A number of factors related to di-
abetes management differed significantly
(P , 0.0001) between the excellent con-
trol and fair/poor control groups (Table 2),
with similar findings among both pump
and injection users (Supplementary
Tables 1–3). Those in the excellent con-
trol group more frequently performed
self-monitoring of blood glucose (SMBG)
(72 vs. 36% reporting SMBG frequency
$5 times/day), including more frequent
SMBG measurements before giving a bo-
lus (56 vs. 32% reporting always doing
this); less frequently missed insulin
doses (94 vs. 55% reporting missing a
dose ,1/week); more often gave a meal-
time insulin bolus before a meal rather
than at the time of or after a meal (69 vs.
54%); and more frequently exercised $3
days/week (72 vs. 59%). In both pump
and injection users, the average total daily
insulin dose was lower in the excellent
control group than in the fair/poor control
group (P, 0.0001), and the ratio of bolus
to basal insulin was higher (P = 0.001). A
comparison of the excellent and fair/poor
control groups on diabetes management
factors is shown in Table 2. At least three
of the four key aspects of diabetesmanage-
ment (SMBG $5 times/day, always per-
forming SMBG before giving a bolus,
giving a meal bolus before the meal, and
missing an insulin dose,1 time/week) were
reported by 62% of the excellent group and
26% of the fair/poor group (P, 0.0001).
Among pump users (Supplementary
Table 2), the excellent control group tended
to have a greater number of basal in-
sulin rate changes per day (3.9 6 2.1 vs.
3.46 2.0, P = 0.001); average duration of
pump insertion was similar in the excel-
lent and fair/poor control groups (3.3 6
0.7 vs. 3.3 6 0.8 days, P = 0.2). Among
injection users (Supplementary Table 3),
most participants in both the excellent
and the fair/poor control groups were
using a regimen that included short- and
long-acting insulins.
Hypoglycemia-induced seizure or
loss of consciousness within the prior
Table 2dComparison of diabetes management characteristics in the excellent and fair/
poor HbA1c control groups
Excellent HbA1c
,6.5% (n = 627)a
Fair/poor HbA1c
$8.5% (n = 1,267)a P value
Self-reported SMBG frequency/day 6.45 6 2.94 4.24 6 2.30 ,0.0001
Times/day
0–2 32 (5) 221 (19)
3–4 137 (23) 538 (45)
5–9 337 (56) 383 (32)
$10 94 (16) 43 (4)
Frequency of SMBG before giving
bolus at time of mealb ,0.0001*
Never/rarely 17 (4) 102 (11)
Sometimes/most of the time 170 (40) 553 (57)
Always 235 (56) 311 (32)
Total daily insulin dose (units/kg/day) 0.54 6 0.26 0.67 6 0.33 ,0.0001
Tertiles
1st (,0.48 units/kg/day) 258 (44) 330 (29)
2nd (0.48–,0.68 units/kg/day) 195 (33) 371 (32)
3rd ($0.68 units/kg/day) 134 (23) 455 (39)
Number of boluses on a typical day 0.006
#2 50 (9) 111 (10)
3–4 316 (54) 725 (63)
$5 217 (37) 308 (27)
Ratio of bolus to basal insulin 1.43 6 2.02 1.10 6 1.70 0.001
Ratio categories
,0.9 191 (34) 542 (51)
0.9–,1.5 193 (35) 333 (31)
$1.5 172 (31) 185 (17)
Bolus given for daytime snacks 0.0003*
Never/ rarely 165 (29) 415 (35)
Sometimes/most of the time 287 (51) 619 (52)
Always 108 (19) 148 (13)
Timing of mealtime insulin bolus ,0.0001
Not given regularly 10 (2) 68 (6)
Before meal 420 (69) 648 (54)
During or after meal 87 (14) 328 (27)
Depends on glucose level prior to meal 89 (15) 167 (14)
Insulin:carbohydrate ratio used to determine
amount of insulin bolus ,0.0001
No/do not know 130 (23) 310 (28)
Yes, all three meals the same 285 (51) 621 (56)
Yes, three meals not all the same 141 (25) 176 (16)
Frequency of missing insulin dose ,0.0001*
Never 426 (70) 390 (32)
,1 time/week 141 (23) 274 (23)
1–2 times/week 31 (5) 286 (24)
$3 times/week 7 (1) 261 (22)
Frequency of exercisec ,0.0001
0 days/week 42 (10) 157 (18)
1–2 days/week 73 (18) 192 (23)
3–5 days/week 201 (50) 360 (42)
6–7 days/week 90 (22) 142 (17)
Composite of four factorsd 2.73 6 0.92 1.69 6 1.17 ,0.0001
Factors
0 3 (1) 215 (18)
1 59 (10) 346 (29)
2 166 (27) 334 (28)
3 250 (41) 229 (19)
4 128 (21) 87 (7)
Data are mean6 SD or n (%). *Mantel-Haenszel x2 statistics. aNumber of participants ranges from 556 to 606
in the excellent control group and from 1,107 to 1,211 in the fair/poor control group, depending on
availability of data for each factor (except for frequency of SMBG and frequency of exercise). bTwo hundred
five participants missing frequency of SMBG data in the excellent control group and 301 in the fair/poor
control group. cTwo hundred twenty-one participants missing frequency of exercise data in the excellent
control group and 416 in the fair/poor control group. dThe composite variable (range 0–4) comprises four
dichotomous items (0/1): bolus before meal, always SMBG before giving a bolus at time of meal, miss doses
,1 time/week, and SMBG frequency $5 times/day.
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12 months was reported by 13% of the
excellent control and 12% of the fair/poor
control groups (P = 0.7). DKA was repor-
ted by 1 and 12%, respectively (P ,
0.0001). Sixty-two percent of the excel-
lent control group described their general
health as very good or excellent compared
with 21% of the fair/poor control group
(P , 0.0001). Fifty percent of the excel-
lent control group reported that they
never or rarely felt stress about their di-
abetes compared with 27% of the fair/
poor control group (P , 0.0001).
CONCLUSIONSdAnalysis of the
large T1D Exchange clinic registry data-
base provided the opportunity to gain a
better understanding of why some adults
with type 1 diabetes achieve better glyce-
mic control than others. Some of the
differentiating features indirectly contrib-
uted, such as income, education level,
health insurance, and marital status,
mostly indicators of higher socioeco-
nomic status that are likely not modifi-
able. This associationwith socioeconomic
status has been demonstrated in pediatric
patients but has not been well studied in
adult populations (4,5). Because poten-
tially modifiable factors associated with
glycemic control are of the most interest,
we intentionally did not adjust for socio-
economic status in evaluating differenti-
ating aspects of diabetes management.
We only considered P , 0.01 to be sig-
nificant in view of the multiple factors
evaluated, and almost all significant asso-
ciations had a P , 0.0001, reflecting the
large sample size. Although it seems un-
likely that differential reporting between
groups would account for the significant
differences found, it is possible that some
of the differences could be underestimates
if participants in the fair/poor control
group misreported some of the informa-
tionmore often than those in the excellent
control group, such as frequency of
missed insulin doses.
Although for all diabetes management
factors there was overlap between the
excellent and fair/poor control groups,
several factors stood out as tending to
differentiate the two groups, particularly
frequency of SMBG measurements, fre-
quency of missing an insulin dose, and
timing of the meal bolus. An association
between SMBG frequency and HbA1c has
been shown in other studies (6–9). The
finding related to timing of the meal bolus
is consistent with findings in patients with
type 1 diabetes describing lower glycemic
excursions when insulin is given 20 min
before a meal compared with immediately
before or 20 min after a meal (10);
however, a randomized crossover study
in type 2 diabetes did not find a beneficial
effect of giving an early bolus before ameal
on HbA1c (11). The observational nature
of the present study precludes a definitive
statement regarding causality. Neverthe-
less, it is important for insurers to consider
that reducing restrictions on the number
of test strips provided per monthmay lead
to improved glycemic control for some pa-
tients with type 1 diabetes, resulting in a
potential cost-savings from both short-
and long-term complications.
Of note, participants with excellent
HbA1c values had lower BMIs, exercised
more frequently, and had lower total daily
insulin dose per kilogram. Although it is
not possible to establish a causal relation-
ship, exercise improves insulin sensitivity
(12), as does lowering BMI (13). The fact
that total daily insulin doses also were
lower suggests that there may be a degree
of insulin resistance in those with the
higher HbA1c levels that could be affected
by an increase in exercise and weight loss.
Additionally, participants with excellent
control were more likely to report an im-
proved sense of overall health as well as
lack of stress about diabetes. Whether
these findings are because of a sense of
self-efficacy resulting in improved diabetes
management orwhether the improved per-
ception of health is related to better diabe-
tes control is difficult to determine. If
improved perception of health leads to im-
proved health, then perhaps counseling
and educational programs can be impor-
tant components of diabetes management.
The lack of an increase in SH in
patients with excellent control compared
with those with fair/poor control is reas-
suring in knowing that a low HbA1c level
can be achieved with a risk for SH that is
no higher than the risk in those with fair/
poor control. This finding differs from
DCCT findings in which there was a
strong association between lower HbA1c
levels as a result of intensive management
and an increase in SH (1). However, but
the finding is consistent with a more re-
cent study (14) that did not demonstrate
an association between lower HbA1c and
frequency of SH episodes. This may be due
to an improvement in insulin management
through the use of short-acting insulin an-
alogs or diabetes education, resulting in ap-
propriate adjustment of insulin doses with
mild hypoglycemia. In contrast, the fre-
quency of DKA, not surprisingly, was
higher in the fair/poor control group.
In conclusion, diabetes self-management
related to insulin delivery, glucose moni-
toring, and lifestyle tends to differ when
comparing adults with type 1 diabetes
under excellent control with those under
poorer control. A better understanding of
the aspects of diabetes self-management
associated with better glycemic control on
the part of patients may lead to improved
control and better long-term outcomes
with lower risk of microvascular and mac-
rovascular complications. Future studies
should focus on modification of dia-
betes management skills in adult patients
with type 1 diabetes who have suboptimal
glycemic control.
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